Association of TNF-α -308 polymorphism with the outcome of hepatitis B virus infection in Turkey

Infection, Genetics and Evolution

Volumn 8, Issue 1, 2008, Pages 20-25

  Basturk, Bilkay ^a   Karasu, Zeki ^b   Kilic, Murat ^b   Ulukaya, Sezgin ^b   Boyacioglu, Sedat ^c   Oral, Barbaros ^d  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

^d ULUDAG UNIVERSITY   (Turkey)

Author keywords

Cytokines; Gene polymorphisms; Hepatic failure; Hepatitis B

Indexed keywords

CYTOKINE; CYTOSINE; GAMMA INTERFERON; GUANINE; INTERLEUKIN 10; INTERLEUKIN 6; THYMINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER FAILURE; MALE; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TURKEY (REPUBLIC); VIRUS CARRIER;

DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; POLYMORPHISM, GENETIC; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; TURKEY;

HEPATITIS B VIRUS;

EID: 36749082117     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2007.09.001     Document Type: Article

References (46)

1. Akalin E., and Murphy B. Gene polymorphisms and transplantation. Curr. Opin. Immunol. 13 (2001) 572-576
2. Alves Oliveira L.F., Moreno E.C., Gazzinelli G., Martins-Filho O.A., Silveira A.M., Gazzinelli A., Malaquias L.C., LoVerde P., Leite P.M., and Correa-Oliveira R. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect. Immun. 74 (2006) 1215-1221
3. Befeler A., and DiBisceglie A. Hepatitits B. In: Koziel M. (Ed). Infectious Disease Clinics of North America vol. 14 (2000), Saunders, Philadelphia 617-632
4. Ben-Ari Z., Mor E., Papo O., Kfir B., Sulkes J., Tambur A.R., Tur-Kaspa R., and Klein T. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am. J. Gastroenterol. 98 (2003) 144-150
5. Bertoletti A., D'Elios M.M., Boni C., De Carli M., Zignego A.L., Durazzo M., Missale G., Penna A., Fiaccadori F., Del Prete G., and Ferrari C. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112 (1997) 193-199
6. Bidwell J.L., Wood N.A., Morse H.R., Keen L.J., Olomolaiye O.O., and Laundy G.J. Human cytokine gene nucleotide sequence aligments. Eur. J. Immunogenet. 26 Suppl. 1 (1998) 135-223
7. Breitkopf K., Haas S., Wiercinska E., Singer M.V., and Dooley S. Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin. Exp. Res. 29 Suppl. (2005) 121-131
8. Buke A.C., Buke M., Altuglu I.E., Ciceklioglu M., Kamcioglu S., Karakartal G., and Huseyinov A. Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. Med. Princ. Pract. 13 (2004) 273-276
9. Chen M.H., Chen J.C., Tsai C.C., Wang W.C., Chang D.C., Tu D.G., and Hsieh H.Y. The role of TGF-beta1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model. J. Ethnopharmacol. 97 (2005) 7-13
10. Cheong J.Y., Cho S.W., Hwang I.L., Yoon S.K., Lee J.H., Park C.S., Lee J.E., Hahm K.B., and Kim J.H. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J. Gastroenterol. Hepatol. 21 July (7) (2006) 1163-1169
11. Chong W.P., To Y.F., Ip W.K., Yuen M.F., Poon T.P., Wong W.H., Lai C.L., and Lau Y.L. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 42 (2005) 1037-1045
12. Cipriano C., Caruso C., Lio D., Giacconi R., Malavolta M., Muti E., Gasparini N., Franceschi C., and Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 32 (2005) 13-18
13. Conway D.J., Holland M.J., Bailey R.L., Campbell A.E., Mahdi O.S., Jennings R., Mbena E., and Mabey D.C. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect. Immun. 65 (1997) 1003-1006
14. Du T., Guo X.H., Zhu X.L., Li J.H., Lu L.P., Gao J.R., Gou C.Y., Li Z., Liu Y., and Li H. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J. Viral Hepat. 13 September (9) (2006) 618-624
15. Esteve M., Saro C., Gonzalez-Huix F., Suarez F., Forne M., and Viver J.M. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 53 (2004) 1363-1365
16. Gewalting J., Mangasser-Stephan K., Gartung C., et al. Association of polymorphisms of the transforming growth factor-B1 gene with the rate of progression of HCV induced liver fibrosis. Clin. Chim. Acta 316 (2002) 828-833
17. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., and Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 (1998) 605-612
18. Ho S.Y., Wang Y.J., Chen H.L., Chen C.H., Chang C.J., Wang P.J., and Chen H.H. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15 (2004) 657-663
19. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Buschenefelde K.H., and Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin. Exp. Immunol. 111 (1998) 579-582
20. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Buschenfelde K.H., and Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J. Med. Virol. 54 3 (1998) 173-177
21. Huggins J.T., and Sahn S.A. Causes and management of pleural fibrosis. Respirology 9 (2004) 441-447
22. Kim Y.J., Lee H.S., Yoon J.H., Kim C.Y., Park M.H., Kim L.H., Park B.L., and Shin H.D. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum. Mol. Genet. 12 (2003) 2541-2546
23. Koziel M.J. Cytokines in viral hepatitis. Semin. Liver Dis. 19 (1999) 157-169
24. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 34 (1997) 391-399
25. Li H.Q., Li Z., Liu Y., Li J.H., Dong J.Q., Gao J.R., Gou C.Y., and Li H. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J. Gastroenterol. 11 (2005) 5213-5217
26. Li H.Q., Li Z., Liu Y., Li J.H., Dong J.Q., Gao J.R., Gou C.Y., and Li H. Association of -238G/A and -857C/T polymorphisms of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection. Biomed. Environ. Sci. 19 April (2) (2006) 133-136
27. Lohr H.F., Gerken G., Schlicht H.J., Meryer zum Buschenfelde K.H., and Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J. Infect. Dis. 168 (1993) 1133-1139
28. Migita K., Miyazoe S., Maeda Y., Daikoku M., Abiru S., Ueki T., Yano K., Nagaoka S., Matsumoto T., Nakao K., Hamasaki K., Yatsuhashi H., Ishibashi H., and Eguchi K. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J. Hepatol. 42 (2005) 505-510
29. Miyazoe S., Hamasaki K., Nakata K., Kajiya Y., Kitajima K., Nakao K., Daikoku M., Yatsuhashi H., Koga M., Yano M., and Eguchi K. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 97 (2002) 2086-2092
30. Niesters H.G., Pas S., and de Man R.A. Detection of hepatitis B virus genotypes and mutants: current status. J. Clin. Virol. 34 Suppl 1 (2005) 4-8
31. Niro G.A., Fontana R., Gioffreda D., Valvano M.R., Lacobellis A., Facciorusso D., and Andriulli A. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int. 25 December (6) (2005) 1175-1181
32. Penna A., Del Prete G., Cavalli A., et al. Predominant T helper 1 cytokine profile of hepatitis B virus nucleocapsid spesfic T cells in acute self-limited hepatitis B. Hepatology 25 (1997) 1022-1027
33. Poli F., Nocco A., Berra S., Scalamogna M., Taioli E., Longhi E., and Sirchia G. Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur. J. Immunogenet. 29 3 (2002) 237-240
34. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., and Hutchinson I.V. In vitro production of IFN-γ correlates with CA repeat polymorphism in IFN-γ gene. Eur. J. Immunogenet. 26 Suppl. 1 (1999) 1-3
35. Reynard M.P., Turner D., and Navarrete C.V. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur. J. Immunogenet. 27 (2000) 241-249
36. Romero R., and Lavine J.E. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 23 (1996) 17-23
37. Rossol S., Marinos G., Carucci P., Singer M.V., Williams R., and Naoumov N.V. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 99 (1997) 3025-3033
38. Somi M.H., Najafi L., Noori B.N., Alizadeh A.H., Aghah M.R., Shavakhi A., Ehsani M.J., Aghazadeh R., Masoodi M., Amini S., Baladast M., and Zali M.R. Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J. Gastroenterol. 25 January-February (1) (2006) 14-15
39. Sugimoto R., Enjoji M., Nakamuta M., Ohta S., Kohjima M., Fukushima M., Kuniyoshi M., Arimura E., Morizono S., Kotoh K., and Nawata H. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 25 (2005) 420-428
40. Tassopoulos N.C., Papaevangelou G.J., Sjogren M.H., et al. Natural history of acute hepatitis B surface antigen hepatitis in Greek adults. Gastroenterology 92 (1987) 1844-1850
41. Tsui L.V., Guidotti L.G., Ishikawa T., and Chisari F.V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12398-12402
42. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24 (1997) 1-8
43. Wang K.X., Peng J.L., Wang X.F., Tian Y., Wang J., and Li C.P. Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. World J. Gastroenterol. 9 (2003) 2017-2020
44. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3195-3199
45. Xu X.W., Lu M.H., and Tan D.M. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin. Microbiol. Infect. 11 (2005) 52-56
46. Zhang L.J., Yu J.P., Li D., Huang Y.H., Chen Z.X., and Wang X.Z. Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats. World J. Gastroenterol. 10 (2004) 77-81